Literature DB >> 22124787

Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathy.

Danping Huang1, Nuo Xu, Yiyue Song, Peijuan Wang, Huasheng Yang.   

Abstract

PURPOSE: To investigate the levels of seven inflammatory cytokines and one chemokine in tears of patients with thyroid-associated ophthalmopathy (TAO) and asymptomatic control subjects, and determine the correlations between tear inflammatory mediators and clinical parameters.
METHODS: Prospective observational cohort study. The study involved 21 patients with TAO and ten asymptomatic controls. TAO patients were divided into active TAO and inactive TAO on the basis of 7-point modified formulation of the clinical activity score (CAS). Ocular Surface Disease Index (OSDI) score, tear film break-up time (BUT) was obtained, and the Schirmer test and fluorescein staining were performed in all participants. Ten microliters of tears were collected for analysis the concentrations of interleukin (IL)-1β, IL-2, IL-6, IL-10, IL-17 interferon (IFN)-γ, tumor necrosis factor (TNF)-α and one chemokine (IL-8) by multiplex bead analysis.
RESULTS: Fluorescein staining scores were higher, BUT scores were shorter, and Schirmer test scores were lower in patients with active TAO and inactive TAO than in control subjects. IL-1β, IL-6, and IL-8 concentrations in tears were significantly higher in active TAO than inactive TAO and the controls. TNF-α concentration was significantly higher in both active and inactive TAO compared with the controls. IL-17 was significantly higher in active TAO than the controls, and the level of IL-2 was significantly higher in inactive TAO compared with the controls. There were significantly positive correlations between tear IL-1β, IL-6 and IL-8 levels and CAS in TAO. No significant correlations were found between other cytokine concentrations and clinical parameters in TAO.
CONCLUSIONS: The differences of tear inflammatory cytokines between patients with active and inactive TAO indicated that orbital inflammation may be involved in the ocular surface damage of TAO.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22124787     DOI: 10.1007/s00417-011-1863-x

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  37 in total

1.  The effect of methylprednisolone pulse treatment on cytokine network in Graves ophthalmopathy.

Authors:  Katarzyna Lacka; Ewa Manuszewska; Izabela Korczowska; Jan K Lacki
Journal:  Curr Eye Res       Date:  2007-03       Impact factor: 2.424

2.  Multiple cytokine analysis in human tears: an optimized procedure for cytometric bead-based assay.

Authors:  Martin W LaFrance; Lucy E Kehinde; Roderick J Fullard
Journal:  Curr Eye Res       Date:  2008-07       Impact factor: 2.424

Review 3.  Cytokines, Graves' disease, and thyroid-associated ophthalmopathy.

Authors:  Andrew G Gianoukakis; Nicole Khadavi; Terry J Smith
Journal:  Thyroid       Date:  2008-09       Impact factor: 6.568

4.  Correlation of orbital computed tomography and antibodies in patients with hyperthyroid Graves' disease.

Authors:  T C Chang; K M Huang; T J Chang; S L Lin
Journal:  Clin Endocrinol (Oxf)       Date:  1990-05       Impact factor: 3.478

5.  Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy.

Authors:  M P Mourits; M F Prummel; W M Wiersinga; L Koornneef
Journal:  Clin Endocrinol (Oxf)       Date:  1997-07       Impact factor: 3.478

6.  Analysis of tear proteins in Graves' ophthalmopathy by high performance liquid chromatography.

Authors:  H A Khalil; R J de Keizer; A Kijlstra
Journal:  Am J Ophthalmol       Date:  1988-08-15       Impact factor: 5.258

Review 7.  Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis, and treatment.

Authors:  D H Jacobson; C A Gorman
Journal:  Endocr Rev       Date:  1984       Impact factor: 19.871

8.  Role of proinflammatory cytokines in the impaired lacrimation associated with autoimmune xerophthalmia.

Authors:  Driss Zoukhri; Robin R Hodges; Dosek Byon; Claire Larkin Kublin
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-05       Impact factor: 4.799

9.  Evaluation of immunological mechanisms mediating thyroid-associated ophthalmopathy by radionuclide imaging using the somatostatin analog 111In-octreotide.

Authors:  R Moncayo; I Baldissera; C Decristoforo; D Kendler; E Donnemiller
Journal:  Thyroid       Date:  1997-02       Impact factor: 6.568

Review 10.  Diagnostic criteria for Graves' ophthalmopathy.

Authors:  G B Bartley; C A Gorman
Journal:  Am J Ophthalmol       Date:  1995-06       Impact factor: 5.258

View more
  23 in total

Review 1.  TFOS DEWS II Tear Film Report.

Authors:  Mark D P Willcox; Pablo Argüeso; Georgi A Georgiev; Juha M Holopainen; Gordon W Laurie; Tom J Millar; Eric B Papas; Jannick P Rolland; Tannin A Schmidt; Ulrike Stahl; Tatiana Suarez; Lakshman N Subbaraman; Omür Ö Uçakhan; Lyndon Jones
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

2.  The tear cytokine profile in patients with active Graves' orbitopathy.

Authors:  Morgan Yang; Yvonne Chung; Stephanie Lang; Nobuyo Yawata; Lay Leng Seah; Audrey Looi
Journal:  Endocrine       Date:  2017-11-16       Impact factor: 3.633

3.  Thyrotropin receptor and CD40 mediate interleukin-8 expression in fibrocytes: implications for thyroid-associated ophthalmopathy (an American Ophthalmological Society thesis).

Authors:  Raymond S Douglas; Tünde Mester; Anna Ginter; Denise S Kim
Journal:  Trans Am Ophthalmol Soc       Date:  2014

Review 4.  Thinking inside the box: Current insights into targeting orbital tissue remodeling and inflammation in thyroid eye disease.

Authors:  Vardaan Gupta; Christine L Hammond; Elisa Roztocil; Mithra O Gonzalez; Steven E Feldon; Collynn F Woeller
Journal:  Surv Ophthalmol       Date:  2021-09-04       Impact factor: 6.197

5.  Changes in cytokines in tears after endoscopic endonasal dacryocystorhinostomy for primary acquired nasolacrimal duct obstruction.

Authors:  J K Lee; T H Kim
Journal:  Eye (Lond)       Date:  2014-02-28       Impact factor: 3.775

6.  The levels of 12 cytokines and growth factors in tears: hyperthyreosis vs euthyreosis.

Authors:  Jelena Juri Mandić; Ana Kozmar; Sanja Kusačić-Kuna; Anamarija Jazbec; Krešimir Mandić; Danijela Mrazovac; Nenad Vukojević
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-01-14       Impact factor: 3.117

7.  Interleukin-7 expression in tears and orbital tissues of patients with Graves' ophthalmopathy.

Authors:  KeBo Cai; RuiLi Wei
Journal:  Endocrine       Date:  2012-11-28       Impact factor: 3.633

8.  Paracrine interactions of thyroid hormones and thyroid stimulation hormone in the female reproductive tract have an impact on female fertility.

Authors:  Anneli Stavreus Evers
Journal:  Front Endocrinol (Lausanne)       Date:  2012-03-30       Impact factor: 5.555

9.  In vivo confocal microscopy assessment of meibomian glands microstructure in patients with Graves' orbitopathy.

Authors:  Shengnan Cheng; Yueqi Yu; Jin Chen; Lin Ye; Xinghua Wang; Fagang Jiang
Journal:  BMC Ophthalmol       Date:  2021-06-19       Impact factor: 2.209

10.  Long-term follow-up of seven patients with ophthalmopathy not associated with thyroid autoimmunity: heterogeneity of autoimmune ophthalmopathy.

Authors:  Tom McCorquodale; Hooshang Lahooti; Bamini Gopinath; Jack R Wall
Journal:  Clin Ophthalmol       Date:  2012-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.